hydroxychloroquine and fluvoxamine

hydroxychloroquine has been researched along with fluvoxamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Blaess, M; Csuk, R; Deigner, HP; Kaiser, L; Sommerfeld, O	1

Reviews

1 review(s) available for hydroxychloroquine and fluvoxamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for hydroxychloroquine and fluvoxamine

Article	Year
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International journal of molecular sciences, 2021, Feb-11, Volume: 22, Issue:4 Topics: Antiviral Agents; Chlorpromazine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Discovery; Drug Repositioning; Fluvoxamine; Humans; Hydroxychloroquine; Interleukin-1; Interleukin-6; Lung; Lysosomes; SARS-CoV-2; Small Molecule Libraries; Virus Replication	2021

Article

Year

Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.

International journal of molecular sciences, 2021, Feb-11, Volume: 22, Issue:4

Topics: Antiviral Agents; Chlorpromazine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Discovery; Drug Repositioning; Fluvoxamine; Humans; Hydroxychloroquine; Interleukin-1; Interleukin-6; Lung; Lysosomes; SARS-CoV-2; Small Molecule Libraries; Virus Replication

2021